DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Bontril PDM (Phendimetrazine Tartrate) - Summary

 
 



BONTRIL PDM SUMMARY

BONTRIL PDM (phendimetrazine tartrate) is a sympathomimetic amine with pharmacological activity similar to the prototype drugs of this class used in obesity, the amphetamines.

Bontril PDM (phendimetrazine tartrate) is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction. The limited usefulness of agents of this class (see CLINICAL PHARMACOLOGY) should be measured against possible risk factors inherent in their use such as those described below.


See all Bontril PDM indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Bontril PDM (Phendimetrazine)

Inadequate sleep during teen years increases risk of obesity
Source: Obesity / Weight Loss / Fitness News From Medical News Today [2014.08.22]
Teenagers who don't get enough sleep may wake up to worse consequences than nodding off during chemistry class.

Midlife Obesity May Boost Dementia Risk
Source: Medscape Psychiatry & Mental Health Headlines [2014.08.21]
Risk for subsequent dementia may be highest in individuals with a first record of obesity during their 30s, but the level of risk appears to diminish with increasing age.
Medscape Medical News

Tax on sugar sweetened drinks may reduce obesity in South Africans
Source: Nutrition / Diet News From Medical News Today [2014.08.21]
A suggested tax on sugar sweetened beverages has been given more credence in a research paper by academics from the University of the Witwatersrand in Johannesburg, South Africa.

Pediatricians Must Act Earlier to Prevent Severe Obesity
Source: Medscape Diabetes & Endocrinology Headlines [2014.08.18]
Physicians need more and better tools to combat child and adolescent obesity to try to reduce the numbers joining the ranks of the severely obese, say 2 experts.
Medscape Medical News

Study backs call for publicly funded obesity surgery in Australia
Source: Obesity / Weight Loss / Fitness News From Medical News Today [2014.08.18]
The push for increased access to publicly funded bariatric surgery for obese Australians has beensupported by new research published in the Medical Journal of Australia.

more news >>

Published Studies Related to Bontril PDM (Phendimetrazine)

Rare case of rhabdomyolysis with therapeutic doses of phendimetrazine tartrate. [2006.03]
Phendimetrazine tartrate is a newer drug that acts as a central stimulant and indirectly acting sympathomimetic with a host of uses similar to the class amphetamines... Additional awareness is needed to educate their patients about the side effects associated with these drugs and to strongly discourage their unsupervised use.

Acute interstitial nephritis following treatment with anorectic agents phentermine and phendimetrazine. [1998.10]
A 47-year-old mildly obese female began a weight reduction program that included anorectic therapy with phentermine and phendimetrazine. A normal urinalysis and serum creatinine were documented at the start of therapy... This case represents the first report of acute interstitial nephritis associated with phentermine or phendimetrazine.

A simple gas chromatographic identification and determination of 11 CNS stimulants in biological samples. Application on a fatality involving phendimetrazine. [1989.02]
A method is presented for the simultaneous identification and quantification of several CNS stimulants, including amphetamine in plasma and urine by GC/FID using mephentermine as an internal standard.

Fatality from illicit phendimetrazine use. [1988]
Phendimetrazine is an anorectic agent which recently has been detected in three medical examiner's cases. In one instance death was attributed to this drug... In the one instance where death was attributed to this substance, the blood concentration was 300 ng/ml.

more studies >>


Page last updated: 2014-08-22

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014